Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis. Rad LM, Hughes KR, Wheeler SN, Decker JT, et al. Proc Natl Acad Sci U S A 2025;122:e2409852122.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rad LM, Hughes KR, Wheeler SN, Decker JT, et al. Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis. Proc Natl Acad Sci U S A 2025;122:e2409852122.
PMID: 39937858